12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. XTL Biopharmaceuticals, Leap Therapeutics, and Jaguar Health were among the top gainers, with increases of 13.9%, 11.21%, and 10.94% respectively. On the downside, Biophytis, Fresh2 Group, and Etao International Co led the losers, with declines of 20.8%, 16.63%, and 14.01% respectively. Notably, Leap Therapeutics' rise followed its Q4 earnings release, and Avinger also reported its Q4 earnings.
March 20, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biophytis shares fell sharply by 20.8% to $0.36, with a market value of $4.0 million.
The significant decline suggests negative investor sentiment or reactions to recent news, likely leading to short-term price pressure.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
Etao International Co shares decreased by 14.01% to $0.23, with a market value of $23.7 million.
The decline may reflect negative investor reaction to company-specific news or unfavorable market conditions.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 80
NEGATIVE IMPACT
Fresh2 Group shares declined by 16.63% to $0.62, with a market value of $14.6 million.
The sharp decline indicates negative market sentiment, potentially due to disappointing company news or broader market trends.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 85
POSITIVE IMPACT
Jaguar Health stock rose 10.94% to $0.09, with a market cap of $18.2 million.
The after-market gain indicates a positive market reaction, possibly due to recent company developments or broader sector movements.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 85
POSITIVE IMPACT
Leap Therapeutics shares increased by 11.21% to $2.84, following its Q4 earnings release.
The positive reaction to the Q4 earnings report indicates strong results or optimistic future guidance, likely boosting short-term investor confidence.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 95
POSITIVE IMPACT
XTL Biopharmaceuticals shares surged 13.9% in after-market trading, with a market value of $14.7 million.
The significant after-market gain suggests positive investor sentiment, potentially leading to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90